Gelonghui, April 3 丨 Recently, Societe Generale Securities released a research report stating that it is optimistic about Feihe's scientific research and innovation-driven and diversified development strategies to maintain its “increase in holdings” rating. According to the research report, as one of the earliest infant formula companies in China, Feihe has closely followed the industry's frontiers over the years, continuously strengthened product research and innovation, and continued to promote the transformation of scientific research results into products, helping the company steadily increase the speed of iterative upgrading of the company's product formulations. At the same time, the company is actively promoting diversified product development. In addition to the regular infant formula series, there are also products such as adult and school milk to further meet the needs of more consumers.